Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

CE-224,535

DRUG

Methotrexate

Trial Locations (5)

Pfizer Investigational Site, Ducansville

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Ocala

Pfizer Investigational Site, Ocala

Pfizer Investigational Site, Kalamazoo